Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q2 2019 · 10-Q
Revenue$19.72M$19.72M+20.2% vs Q2 2018 Net Income$381.00K$381.00KN/M vs Q2 2018 EPS Diluted$0.02$0.02N/M vs Q2 2018 Gross Profit$11,356,000+17.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Operating Cash Flowderived$3,050,000−19.6% Free Cash Flowderived$6,287,000+189.7% Margins · derivedGross margin57.6%−1.4 pt vs Q2 2018
Operating margin4.9%+6.2 pt vs Q2 2018
Net margin1.9%+5.0 pt vs Q2 2018
ended Jun 30, 2019 · filed Aug 14, 2019 · 45 d after period end